Simon Farrell — SEC Form 4 filings
SEC reporting owner CIK 1965585. 6 Form 4 filings on record with FilingPulse; latest filed 2026-07-23.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-16 to 2026-07-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 81,313 shares, $548,878 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 76,963 shares @ $6.73 ($517,776) in Trevi Therapeutics, Inc., filed 2025-03-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Trevi Therapeutics, Inc. (TRVI) | Chief Commercial Officer | 5 | — | 2 legs · 81,313 sh · $548,878 | 11 |
| Serina Therapeutics, Inc. (SER) | Director | 1 | — | — | 1 |
Form 4 filings — Simon Farrell
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-23 | 4 | Serina Therapeutics, Inc. (SER) | Grant/award (A): 30,500 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 160,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 17,500 @ $3.21 · Option exercise (M): 63,813 @ $3.91 · Option exercise (M): 31,250 @ $0.51 · Sale (S): 76,963 @ $6.73 · Sale (S): 4,350 @ $7.15 · Grant/award (A): 38,400 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 225,500 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1965585 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →